Literature DB >> 1975172

Glutathione-degrading capacities of liver and kidney in different species.

C A Hinchman1, N Ballatori.   

Abstract

Although the liver is recognized as a major site of glutathione (GSH) synthesis, it is thought to play only a minor role in GSH catabolism. This is primarily because in the rat, the most commonly used experimental animal, hepatic gamma-glutamyltransferase (gamma-GT) activity is very low, whereas kidney activity is quite high. gamma-GT is the only enzyme known to catalyze the initial step in GSH degradation. The present work compares gamma-GT and dipeptidase activities in liver, kidney, and gallbladder of six mammalian species to assess the importance of hepatobiliary catabolism of GSH, relative to renal degradation. Marked species differences were observed in gamma-GT activities, and in kidney to liver (K/L) ratios for both gamma-GT concentration (milliunits/mg protein) and whole organ activities (total activity per liver or two kidneys). The K/L concentration ratios for gamma-GT activities ranged from 875 in the rat to 15 in the guinea pig. Whole organ gamma-GT ratios were approximately 150 in mouse and rat, and only 2-5 in guinea pig. pig, and macaque. Human K/L ratios calculated from gamma-GT activities reported previously were similar to those of the guinea pig. Species differences were also observed in K/L ratios for dipeptidase activities, though these differences were not as large as those for gamma-GT, gamma-GT and dipeptidase activities were also measured in gallbladders of all species examined (except rat which does not have this organ), and were found to be comparable to those of liver. These results suggest that in species such as the guinea pig and perhaps humans, the liver and biliary tree play a prominent role in GSH turnover. Because of the low hepatic and high renal gamma-GT activities of the rat, and because it does not have a gallbladder, this species may not be the best model for studying the catabolism of GSH and GSH conjugates. Use of the rat model may underestimate the contribution of liver, and overestimate that of kidney, in these degradative processes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975172     DOI: 10.1016/0006-2952(90)90503-d

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  23 in total

1.  Placenta as a target of trichloroethylene toxicity.

Authors:  Elana R Elkin; Sean M Harris; Anthony L Su; Lawrence H Lash; Rita Loch-Caruso
Journal:  Environ Sci Process Impacts       Date:  2020-02-05       Impact factor: 4.238

Review 2.  Mitochondrial glutathione transport: physiological, pathological and toxicological implications.

Authors:  Lawrence H Lash
Journal:  Chem Biol Interact       Date:  2006-04-04       Impact factor: 5.192

3.  Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice.

Authors:  M W Lieberman; A L Wiseman; Z Z Shi; B Z Carter; R Barrios; C N Ou; P Chévez-Barrios; Y Wang; G M Habib; J C Goodman; S L Huang; R M Lebovitz; M M Matzuk
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

4.  Role of rat organic anion transporter 3 (Oat3) in the renal basolateral transport of glutathione.

Authors:  Lawrence H Lash; David A Putt; Feng Xu; Larry H Matherly
Journal:  Chem Biol Interact       Date:  2007-07-19       Impact factor: 5.192

Review 5.  Trichloroethylene biotransformation and its role in mutagenicity, carcinogenicity and target organ toxicity.

Authors:  Lawrence H Lash; Weihsueh A Chiu; Kathryn Z Guyton; Ivan Rusyn
Journal:  Mutat Res Rev Mutat Res       Date:  2014 Oct-Dec       Impact factor: 5.657

6.  Stereoselective flunoxaprofen-S-acyl-glutathione thioester formation mediated by acyl-CoA formation in rat hepatocytes.

Authors:  Mark P Grillo; Jill C M Wait; Michelle Tadano Lohr; Smriti Khera; Leslie Z Benet
Journal:  Drug Metab Dispos       Date:  2010-01       Impact factor: 3.922

Review 7.  Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology.

Authors:  Nazzareno Ballatori; Suzanne M Krance; Rosemarie Marchan; Christine L Hammond
Journal:  Mol Aspects Med       Date:  2008-08-26

8.  Characterization of a novel dithiocarbamate glutathione reductase inhibitor and its use as a tool to modulate intracellular glutathione.

Authors:  Teresa Seefeldt; Yong Zhao; Wei Chen; Ashraf S Raza; Laura Carlson; Jocqueline Herman; Adam Stoebner; Sarah Hanson; Ryan Foll; Xiangming Guan
Journal:  J Biol Chem       Date:  2008-12-02       Impact factor: 5.157

9.  Role of renal gamma-glutamyltransferase activity in hepatic utilization of exogenous glutathione.

Authors:  T Tamano; H Yoshida; Y Kuronuma; T Harada
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

10.  Characterization of the acyl-adenylate linked metabolite of mefenamic Acid.

Authors:  Howard Horng; Leslie Z Benet
Journal:  Chem Res Toxicol       Date:  2013-02-26       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.